Exhibit 99.1

 

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value $0.02288 per share, of newcleo plc and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.

 

The undersigned further agree that each party hereto is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein; provided, however, that no party is responsible for the completeness or accuracy of the information concerning any other party making the filing, unless such party knows or has reason to believe that such information is inaccurate.

 

IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement on October 15, 2026.

 

  ELYSIA CAPITAL I SCSP
By: Elysia GP S.à r.l., its general partner
   
  By: /s/ David Luksenburg
 

Name: David Luksenburg 

Title: Class B Manager of Elysia GP S.à r.l., the 

General Partner of Elysia Capital I SCSp 

   
   
  STEFANO BUONO
   
  /s/ Stefano Buono  
  Stefano Buono, individually